Summary:
Northwest Health Care Associates is conducting a 12-week, randomized, placebo-controlled study of the safety and efficacy of Plecanatide in patients with Irritable Bowel Syndrome with Constipation.
Qualified Participants Must:
• Be between 18 and 85 years of age
•
Have a diagnosis of IBS with constipation
Qualified Participants May Receive:
Study medication, all study visits, diagnostic tests, and $300 for full study participation.